Drugs / Carbidopa/Levodopa
last change Jan 2019 re-read 2 minutes ago

Carbidopa/Levodopa

Developed for
Parkinson disease
Investigated by
Intec Pharma Ltd.

Trials 1 · a red edge is where a trial was stopped

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03576638 Jul 2018 → Jan 2019 Parkinson disease Intec Pharma Ltd. Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Carbidopa/Levodopa ClinicalTrials.gov intervention name — accepted as the source's own label NCT03576638